Synapse - Tiffany Traina

Results (253)

TBCRC 030: A randomized phase II study of preoperative cisplatin versus paclitaxel in TNBC-Evaluating the homologous recombination deficiency (HRD) biomarker

Meeting Abstract

Mayer, E. L.; Abramson, V. G.; Jankowitz, R. C.; Falkson, C. I.; Marcom, P. K.; Traina, T. A.; Carey, L. A.; Rimawi, M. F.; Specht, J. M.; Miller, K.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Emerging novel therapeutics in triple-negative breast cancer

Journal Article

Lyons, T. G.; Traina, T. A.
Advances in Experimental Medicine and Biology (2019)

Fulltext@MSK | Save

Prognostic role of androgen receptor in triple negative breast cancer: A multi-institutional study

Journal Article

Bhattarai, S.; Klimov, S.; Mittal, K.; Krishnamurti, U.; Li, X. B.; Oprea-Ilies, G.; Wetherilt, C. S.; Riaz, A.; Aleskandarany, M. A.; Green, A. R.; more...
Cancers (2019)

Fulltext@MSK | Save

Male breast cancer: A disease distinct from female breast cancer

Review

Gucalp, A.; Traina, T. A.; Eisner, J. R.; Parker, J. S.; Selitsky, S. R.; Park, B. H.; Elias, A. D.; Baskin-Bey, E. S.; Cardoso, F.
Breast Cancer Research and Treatment (2019)

Fulltext@MSK | Save

Hepatotoxicity after radioembolization for liver metastases due to breast cancer in the setting of systemic therapy

Meeting Abstract

Kulkarni, S.; Yarmohammadi, H.; Sofocleous, C.; Gonzalez Aguirre, A.; Bryce, Y.; Boas, F.; Bromberg, J.; Wong, S.; Traina, T.; Deipolyi, A.
Journal of Vascular and Interventional Radiology (2019)

Fulltext@MSK | Save

Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis

Meeting Abstract

Tio, M.; Patil, S.; Traina, T. A.; Robson, M. E.; Khasraw, M.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A randomized phase II trial of carboplatin with or without nivolumab in first- or second-line metastatic TNBC

Meeting Abstract

Garrido-Castro, A. C.; Barry, W. T.; Traina, T. A.; Wesolowski, R.; Tung, N. M.; Keenan, T.; Van Allen, E. M.; Lin, N. U.; Winer, E. P.; Krop, I. E.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer

Meeting Abstract

Lyons, T.; Gucalp, A.; Arumov, A.; Patil, S.; Edelweiss, M.; Gorsky, M.; Troso-Sandoval, T. A.; Bromberg, J.; Sanford, R. A.; Iyengar, N. M.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage human epidermal growth factor receptor 2–negative breast cancer